- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03186066
Endoscopic Treatment of the Buried Bumper Syndrome: Comparison of the Flamingo Device Versus Standard Therapy (ESCAPE)
A Prospective Randomized Controlled Multicenter Trial for Evaluation of the Flamingo Device in Endoscopic Treatment of the Buried Bumper Syndrome.
Percutaneous endoscopic gastrostomy (PEG) is a method for nutrition delivery for patients with insufficient oral intake. A rare but severe complication of PEG is the Buried Bumper Syndrome (BBS). In BBS the internal fixation device of the PEG migrates along the stoma chanel. The internal fixation disc becomes covered by gastric mucosa, which causes loss of patency, fixation of the PEG and possible leakage around the PEG.
BBS can be treated endoscopically by dissecting the overgrowing tissue with endoscopic submucosal dissection (ESD) knifes. A new and alternative approach is the use of the Flamingo device, which is inserted over the PEG and then is used to radially dissect the overgrowing tissue with a cutting wire.
In this study both methods, the standard method using an ESD knife and the Flamingo device, are compared in a randomized controlled open-label trial. Primary endpoint is the time needed for PEG removal.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ludwigsburg, Germany, 71640
- Klinikum Ludwigsburg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Endoscopy proven Buried Bumper Syndrome
- PEG or Jet-PEG
Exclusion Criteria:
- Major Coagulation disorder
- Percutaneous endoscopic jejunostomy or use of a ballon fixed device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard Therapy
Buried Bumper Syndrome is treated by endoscopically dissecting the overgrown tissue with an endoscopic submucosal dissection knife.
|
Endoscopic Treatment of Buried Bumper Syndrome with an endoscopic submucosal dissection knife
|
|
Experimental: Flamingo Device
The Flamingo device is used for treatment of Buried Bumper Syndrome.
|
Endoscopic Treatment of Buried Bumper Syndrome with the Flamingo Device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Time for Removal of PEG
Time Frame: Assessed at day 1 (day of intervention)
|
Assessed at day 1 (day of intervention)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Success rate
Time Frame: Assessed at day 1
|
Assessed at day 1
|
|
Complications
Time Frame: Assessed during follow-up for up to ten days
|
Assessed during follow-up for up to ten days
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Escape
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Buried Bumper Syndrome
-
University of PittsburghNot yet recruitingPenis/Surgery | Penis/Injuries | Penile Skin | Adult-Acquired Buried PenisUnited States
-
GlaxoSmithKlineNot yet recruiting
-
Rutgers, The State University of New JerseyRecruitingMicrodeletion 3q29 Syndrome | Microduplication 3q29 SyndromeUnited States
-
Lokman Hekim UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Rotator Cuff Impingement SyndromeTurkey (Türkiye)
-
Unravel Biosciences, Inc.RecruitingPitt Hopkins SyndromeColombia
-
Neumedicines Inc.Department of Health and Human ServicesCompletedHematopoietic Syndrome Due to Acute Radiation SyndromeUnited States
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Ministry of Public Health, Democratic Republic...National Institutes of Health (NIH); Oregon Health and Science University; National... and other collaboratorsCompletedNeurotoxicity Syndrome, Cassava | Neurotoxicity Syndrome, Cyanate | Neurotoxicity Syndrome, Cyanide | Neurotoxicity Syndrome, ThiocyanateCongo, The Democratic Republic of the
-
Charite University, Berlin, GermanyRecruiting
Clinical Trials on Standard Therapy
-
Castilla-La Mancha Health ServiceComplejo Hospitalario La Mancha CentroCompletedSubacromial Impingement Syndrome | Vojta TherapySpain
-
Institute of Cardiology, Warsaw, PolandUnknownCardiac RehabilitationPoland
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Swiss Group for Clinical Cancer ResearchTerminatedMetastatic Colorectal CancerSwitzerland, Austria
-
University of Alabama at BirminghamWithdrawn
-
Emory UniversityNational Cancer Institute (NCI); National Center for Complementary and Integrative...Active, not recruitingLymphoma | Multiple MyelomaUnited States
-
CardioRenal Systems, Inc.Active, not recruitingContrast Induced NephropathyUnited States
-
Shanghai Zhongshan HospitalNot yet recruitingGastric / Gastroesophageal Junction AdenocarcinomaChina
-
Dana-Farber Cancer InstituteRecruitingCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States